最新消息
獲取55%折扣優惠 0
🏃 黑五大促,早買早享受。Investing Pro 高達55%折扣,就趁現在!
獲取優惠
關閉

Fidelity Select Biotechnology Portfolio(FBIOX)

建立提醒
新的!
建立提醒
網站
  • 作為提醒通知
  • 您要登陸到您的賬戶才能使用此功能
移動應用程序
  • 您要登陸到您的賬戶才能使用此功能
  • 請確保您使用相同的用戶資料登入

條件

頻率

一次
%

頻率

頻率

傳達方式

狀態

從投資組合中新增/移除 新增至觀察名單
加入觀察名單
新增持倉盤

頭寸被成功添加到:

請為您的持倉投資組合命名
 
21.31 -0.73    -3.31%
12/11 - 延遲資料. USD 貨幣
種類:  基金
市場:  美國
發行者:  Fidelity Investments
相關:  S&P 500 TR
資產類別:  股票
  • 晨星評級:
  • 總資產: 4.89B
Fidelity Select Biotechnology 21.31 -0.73 -3.31%

FBIOX綜觀

 
你可在本頁找到深入的Fidelity Select Biotechnology Portfolio公司檔案,包括FBIOX的主要管理層、總資產、投資策略及聯絡資料,以及各類其他資訊。
類別

Health

總資產

4.89B

費用

0.64%

基金成立

1985年12月16日

聯絡資訊

地址 483 Bay Street
Toronto,ON M5G 2N7
Canada
電話 416-307-5200
傳真 1-800-387-8092

主要管理層

名稱 主旨 成立於 直至
Rajiv Kaul Portfolio Manager 2005 now
自傳 Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.
Harlan P. Carere Portfolio Manager 2004 2005
自傳 Carere is a portfolio manager of Fidelity Investments. He joined Fidelity International Limited in London in 2000 as an equity research analyst following the technology sector. He subsequently served as technology sector leader in the London office. Prior to joining the firm, he was an equity analyst for Berman Capital.
Andraz Razen Vice President 2002 2004
自傳 Andraz Razen is an equity portfolio manager at Capital Group. As an equity investment analyst at Capital, Andraz is a generalist covering small-cap companies. He has 25 years of investment experience and has been with Capital Group for 18 years. Earlier in his career, as an equity investment analyst at Capital, he also covered U.S. health care and supplies companies. Prior to joining Capital, he was an analyst and portfolio manager at Fidelity Investments in Boston. He holds a bachelor's degree in quantitative economics from Tufts University graduating summa cum laude. Andraz is based in London.
Brian Younger Research Analyst, Portfolio Manager 2000 2002
自傳 Younger is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in June 1998, he has worked as a research analyst and portfolio manager.
Yolanda S. Strock equity analyst/portfolio Manager 2000 2000
自傳 Yolanda Strock joined Fidelity in 1997 where she is the sector leader of the Health Care Equity Resesarch group. She began managing Fidelity Select Biotechnology Portfolio in February 2000, and assumed her other fund management responsibilities and role of sector leader in June 2000. Yolanda has an MBA in Finance from the Fuqua School of Business at Duke University, a BSc in Marketing from the Wharton School of Business and a BA in economics from the University of Pennsylvania.
Rajiv Kaul Portfolio Manager 1998 2000
自傳 Kaul is a portfolio manager with Fidelity Investments. Since joining Fidelity Investments in 1996, he has worked as a research analyst and portfolio manager. Kaul also manages another Fidelity fund. Prior to Fidelity, Kaul worked at Mckinsey & Company. He is the recipient of the Kann Rasmusson Environment Award, the Dean's Summer Research Award and a Ford Undergraduate Fellowship.
James M. Harmon Portfolio Manager 1997 1998
自傳 Mr. Harmon is a portfolio manager with Fidelity Investments, his employer since 1995. He joined the firm as an equity analyst covering biotechnology and smaller health-care services companies. Previously, Mr. Harmon has worked as a research analyst, portfolio assistant in Fidelity Investments. Before that he was a junior analyst with Essex Investment Management Co., Inc.
Karen Firestone - 1992 1997
Michael S. Gordon Portfolio Manager 1990 1992
自傳 Gordon has been a portfolio manager with Fidelity Investments since 1990. He joined Fidelity Investments in June 1987 as a research analyst covering initial public offerings.
Steven Kaye Co-Manager 1985 1989
自傳 Kaye is a vice president and portfolio manager with Fidelity Management & Research. Previously, he was head of Fidelity Select Portfolios and assistant director of research. Since joining Fidelity Investments in 1985, Mr. Kaye has worked as a research analyst, assistant director of equity research, and portfolio manager. Before joining the firm, he spent two years as a research analyst with Strategic Planning Associates.
評論守則
我们鼓励您使用评论,与用户沟通,共享您的观点并向作者及互相提问。 但是,为了获得有价值和期待的高水平评论,请注意以下标准:
  • 丰富对话
  • 保持关注及正确方向。 只发布与所讨论话题相关的材料。
  • 保持尊重。 即使是负面的意见,也可以用积极的外交辞令进行组织。
  • 用标准书写风格。 包括标点和大小写。
  • 注: 评论中如有垃圾和/或促销信息和链接都将被删除。
  • 避免亵渎、诽谤或人身攻击,对于作者或其他用户。
  • 仅允许中文评论。

垃圾邮件或滥发信息的肇事者都将被从网站删除并禁止以后进行注册,这由Investing.com自由决定。

FBIOX評論

寫下您對Fidelity Select Biotechnology Portfolio的看法
 
確定要刪除這個圖表?
 
留言
也張貼至:
 
用新的圖表更換附上的圖表?
1000
由於收到負面的用戶報告,你的評論功能已被暫停。你的狀態會由版主審核。
請等待一分鐘后再次發表評論。
感謝您的評論。請註意,所有的評論都需要我們版主的批準。因此,可能過一些時間您的評論才會出現在我們的網站上。
 
確定要刪除這個圖表?
 
留言
 
用新的圖表更換附上的圖表?
1000
由於收到負面的用戶報告,你的評論功能已被暫停。你的狀態會由版主審核。
請等待一分鐘后再次發表評論。
在留言中加插圖表
確認封鎖

你確定要封鎖 %USER_NAME%?

此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。

%USER_NAME% 已成功加入你的封鎖清單

你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。

舉報此評論

我覺得這個評論是:

評論被加標記

謝謝!

您的報告已被發送到我們的版主審核
使用 Apple 登入
以 Google 登入
以電子郵件註冊